105 related articles for article (PubMed ID: 1361298)
1. E rosette formation in B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Buda G; Squadrito G
Acta Haematol; 1992; 88(2-3):151-3. PubMed ID: 1361298
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemia B-lymphocytes forming SRBC-rosettes not due to an anti-SRBC activity of monoclonal surface immunoglobulin.
Herrmann F; Kolecki P; Sieber G; Ludwig WD; Komischke B; Rühl H
Am J Clin Pathol; 1985 Feb; 83(2):249-53. PubMed ID: 3871584
[TBL] [Abstract][Full Text] [Related]
3. Poorly expressed CD2 antigen on the leukemic cells of adult T-cell leukemia and chronic lymphocytic leukemia of T-cell lineage.
Tamura K; Sagawa K; Satoh H; Torigoe J; Kimura N; Araki Y; Makino S
Leuk Res; 1989; 13(1):93-9. PubMed ID: 2563408
[TBL] [Abstract][Full Text] [Related]
4. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous expression of CD2 on a B-cell, small lymphocytic neoplasm.
Viciana AL; Lancet FC; Chamizo W; Voigt W; Ruiz P
Cytometry; 1994 Mar; 18(1):42-8. PubMed ID: 7915983
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte-rosette receptor expression by chronic lymphocytic leukemia B lymphocytes.
Guglielmi P; Preud'homme JL; Brouet JC
Eur J Immunol; 1983 Aug; 13(8):641-6. PubMed ID: 6603981
[TBL] [Abstract][Full Text] [Related]
7. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
8. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
Popova L; Apostolov P; Vlaĭkova S; Stamenova L
Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
[TBL] [Abstract][Full Text] [Related]
9. The importance of surface immunoglobulin, mouse rosettes, and CD5 in the immunophenotyping of chronic lymphocytic leukemia and reactive lymphocytosis.
Batata A; Shen B
Cancer; 1991 Jul; 68(2):355-61. PubMed ID: 2070335
[TBL] [Abstract][Full Text] [Related]
10. Binding of sheep erythrocytes in chronic lymphocytic leukemias of B-cell origin.
Semenzato G; Pizzolo G; Gerosa F; Pandolfi F; Pezzutto A; Andrighetto GC; Quinti I; Agostini C; Foa R; Tridente G
J Clin Immunol; 1982 Oct; 2(4):296-302. PubMed ID: 6815221
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of TRBC receptor and E receptor on T lymphocytes of human and macaque].
Zheng YT; Ben KL; Zheng WF
Shi Yan Sheng Wu Xue Bao; 1990 Mar; 23(1):51-6. PubMed ID: 1974378
[TBL] [Abstract][Full Text] [Related]
12. Induction of immature-B-cell phenotype, mouse-erythrocyte-rosette receptor expression, by mitogen treatment of normal peripheral B-cells.
Ozgün S; Akoğlu T
Br J Haematol; 1991 May; 78(1):139-40. PubMed ID: 2043475
[No Abstract] [Full Text] [Related]
13. All CD2-positive human lymphocytes rosette with sheep erythrocytes in the presence of polyethylene glycol.
Ocklind G
J Immunol Methods; 1988 Sep; 112(2):169-72. PubMed ID: 2901445
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxicity of poly-drug use: abnormalities in the active and high-affinity CD2 antigen (E-rosette receptor) bearing T-lymphocytes.
Nair BS; Erickson JR; Pillai R; Estrada A; Watson RR
Toxicol Lett; 1991 Aug; 57(3):339-45. PubMed ID: 1679260
[TBL] [Abstract][Full Text] [Related]
15. Expression of the CD2 molecule on human B lymphoid progenitors.
Muraguchi A; Kawamura N; Hori A; Horii Y; Ichigi Y; Kimoto M; Kishimoto T
Int Immunol; 1992 Aug; 4(8):841-9. PubMed ID: 1384685
[TBL] [Abstract][Full Text] [Related]
16. Spurious E rosette formation in B cell chronic lymphocytic leukemia due to monoclonal anti-sheep RBC antibody.
Mills LE; O'Donnell JF; Guyre PM; LeMarbre PJ; Miller JD; Bernier GM
Blood; 1985 Feb; 65(2):270-4. PubMed ID: 3871340
[TBL] [Abstract][Full Text] [Related]
17. Dog erythrocyte rosette-forming lymphocyte: blockage by OKT11 monoclonal antibody.
Nishiya K; Yamamura M; Hatano M; Amano T; Suzuki S; Ota Z
Acta Med Okayama; 1987 Feb; 41(1):37-41. PubMed ID: 3105252
[TBL] [Abstract][Full Text] [Related]
18. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
[TBL] [Abstract][Full Text] [Related]
19. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
Aydar S; Oğüt A; Undük H; Gündüz M
New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
[No Abstract] [Full Text] [Related]
20. Mouse erythrocyte rosette formation with malignant human B-lymphocytes re-evaluated: still a useful marker for differentiating mature B-cell malignancies.
Hokland P; Geisler CH; Andersen E; Drivsholm A; Hansen MM; Meyer K
Br J Haematol; 1992 Nov; 82(3):560-4. PubMed ID: 1283079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
